Kastalia Medrano

    Kastalia is Filter‘s deputy editor. She previously worked at half a dozen mainstream digital media outlets and would not recommend the drug coverage at any of them. For a while she was a syringe program peer worker in NYC, where she did outreach hep C testing and navigated participants through treatment. She also writes with Jon Kirkpatrick.

    The FDA Draft Guidance for Stimulant Use Disorder Medication Is… Decent

    One of the reasons we have Food and Drug Administration-approved medications for opioid use ...

    SAMHSA’s National Drug Use Survey Has a Fentanyl Problem

    Up through 2021, the Substance Abuse and Mental Health Services Administration (SAMHSA) national drug ...

    China to Target Fentanyl Precursors, Deepening the Synthetic Drug War

    China has reportedly agreed to crack down on companies that manufacture and export fentanyl ...

    DEA Targets Precursors, Pill Presses in Fentanyl Supply Chain Crackdown

    In the aftermath of the temporary class-wide fentanyl ban the Drug Enforcement Administration (DEA) ...

    It’s Fentanyl Misinformation Season. Please Consume Media Responsibly.

    Every year, the Drug Enforcement Administration (DEA) gets a few more allies in its ...

    OTC Narcan Arrives at Pharmacies, a Stepping Stone to Broader Access

    The first week of September has seen major pharmacy chains across the United States ...

    CDC: Counterfeit Pill Overdose Deaths More Than Doubled During Pandemic

    A September 1 report from the Centers for Disease Control and Prevention found that ...

    Vyvanse, “Abuse-Deterrent” Stimulant, Goes Generic in ADHD Med Shortage

    The Food and Drug Administration has approved the first generic versions of Vyvanse, the ...